These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 22182667)

  • 1. A randomized trial of family focused treatment for adolescents and young adults at risk for psychosis: study rationale, design and methods.
    Schlosser DA; Miklowitz DJ; O'Brien MP; De Silva SD; Zinberg JL; Cannon TD
    Early Interv Psychiatry; 2012 Aug; 6(3):283-91. PubMed ID: 22182667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Family-focused treatment for adolescents and young adults at high risk for psychosis: results of a randomized trial.
    Miklowitz DJ; O'Brien MP; Schlosser DA; Addington J; Candan KA; Marshall C; Domingues I; Walsh BC; Zinberg JL; De Silva SD; Friedman-Yakoobian M; Cannon TD
    J Am Acad Child Adolesc Psychiatry; 2014 Aug; 53(8):848-58. PubMed ID: 25062592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Family-focused therapy for individuals at high clinical risk for psychosis: A confirmatory efficacy trial.
    Miklowitz DJ; Addington JM; O'Brien MP; Denenny DM; Weintraub MJ; Zinberg JL; Mathalon DH; Cornblatt BA; Friedman-Yakoobian MS; Stone WS; Cadenhead KS; Woods SW; Sugar CA; Cannon TD; Bearden CE
    Early Interv Psychiatry; 2022 Jun; 16(6):632-642. PubMed ID: 34427047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Family-focused therapy for individuals at clinical high risk for psychosis: treatment fidelity within a multisite randomized trial.
    Marvin SE; Miklowitz DJ; O'Brien MP; Cannon TD
    Early Interv Psychiatry; 2016 Apr; 10(2):137-43. PubMed ID: 24725329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreases in perceived maternal criticism predict improvement in subthreshold psychotic symptoms in a randomized trial of family-focused therapy for individuals at clinical high risk for psychosis.
    O'Brien MP; Miklowitz DJ; Cannon TD
    J Fam Psychol; 2015 Dec; 29(6):945-51. PubMed ID: 26168262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A randomized trial of family focused therapy with populations at clinical high risk for psychosis: effects on interactional behavior.
    O'Brien MP; Miklowitz DJ; Candan KA; Marshall C; Domingues I; Walsh BC; Zinberg JL; De Silva SD; Woodberry KA; Cannon TD
    J Consult Clin Psychol; 2014 Feb; 82(1):90-101. PubMed ID: 24188511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and functional outcomes after 2 years in the early detection and intervention for the prevention of psychosis multisite effectiveness trial.
    McFarlane WR; Levin B; Travis L; Lucas FL; Lynch S; Verdi M; Williams D; Adelsheim S; Calkins R; Carter CS; Cornblatt B; Taylor SF; Auther AM; McFarland B; Melton R; Migliorati M; Niendam T; Ragland JD; Sale T; Salvador M; Spring E
    Schizophr Bull; 2015 Jan; 41(1):30-43. PubMed ID: 25065017
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intervention for adolescents with early-onset psychosis and their families: a randomized controlled trial.
    Calvo A; Moreno M; Ruiz-Sancho A; Rapado-Castro M; Moreno C; Sánchez-Gutiérrez T; Arango C; Mayoral M
    J Am Acad Child Adolesc Psychiatry; 2014 Jun; 53(6):688-96. PubMed ID: 24839887
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Family communication with teens at clinical high-risk for psychosis or bipolar disorder.
    Salinger JM; O'Brien MP; Miklowitz DJ; Marvin SE; Cannon TD
    J Fam Psychol; 2018 Jun; 32(4):507-516. PubMed ID: 29389150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary prevention of psychosis through interventions in the symptomatic prodromal phase, a pragmatic Norwegian Ultra High Risk study.
    Joa I; Gisselgård J; Brønnick K; McGlashan T; Johannessen JO
    BMC Psychiatry; 2015 Apr; 15():89. PubMed ID: 25897797
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Family problem solving interactions and 6-month symptomatic and functional outcomes in youth at ultra-high risk for psychosis and with recent onset psychotic symptoms: a longitudinal study.
    O'Brien MP; Zinberg JL; Ho L; Rudd A; Kopelowicz A; Daley M; Bearden CE; Cannon TD
    Schizophr Res; 2009 Feb; 107(2-3):198-205. PubMed ID: 18996681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rationale and baseline characteristics of PREVENT: a second-generation intervention trial in subjects at-risk (prodromal) of developing first-episode psychosis evaluating cognitive behavior therapy, aripiprazole, and placebo for the prevention of psychosis.
    Bechdolf A; Müller H; Stützer H; Wagner M; Maier W; Lautenschlager M; Heinz A; de Millas W; Janssen B; Gaebel W; Michel TM; Schneider F; Lambert M; Naber D; Brüne M; Krüger-Özgürdal S; Wobrock T; Riedel M; Klosterkötter J;
    Schizophr Bull; 2011 Sep; 37 Suppl 2(Suppl 2):S111-21. PubMed ID: 21860040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a group and family-based cognitive behavioural therapy program for youth at risk for psychosis.
    Landa Y; Mueser KT; Wyka KE; Shreck E; Jespersen R; Jacobs MA; Griffin KW; van der Gaag M; Reyna VF; Beck AT; Silbersweig DA; Walkup JT
    Early Interv Psychiatry; 2016 Dec; 10(6):511-521. PubMed ID: 25585830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing adolescent preference in the treatment of first-episode psychosis and psychosis risk.
    Welsh P; Tiffin PA
    Early Interv Psychiatry; 2014 Aug; 8(3):281-5. PubMed ID: 23870289
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based early interventions for individuals at clinical high risk for psychosis: a review of treatment components.
    Thompson E; Millman ZB; Okuzawa N; Mittal V; DeVylder J; Skadberg T; Buchanan RW; Reeves GM; Schiffman J
    J Nerv Ment Dis; 2015 May; 203(5):342-51. PubMed ID: 25919384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline psychopathology and relationship to longitudinal functional outcome in attenuated and early first episode psychosis.
    Burton CZ; Tso IF; Carrión RE; Niendam T; Adelsheim S; Auther AM; Cornblatt BA; Carter CS; Melton R; Sale TG; Taylor SF; McFarlane WR
    Schizophr Res; 2019 Oct; 212():157-162. PubMed ID: 31395490
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): a multicentre, three-arm, randomised controlled pilot and feasibility study.
    Morrison AP; Pyle M; Maughan D; Johns L; Freeman D; Broome MR; Husain N; Fowler D; Hudson J; MacLennan G; Norrie J; Shiers D; Hollis C; James A;
    Lancet Psychiatry; 2020 Sep; 7(9):788-800. PubMed ID: 32649925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early detection and integrated care for adolescents and young adults with severe psychotic disorders: rationales and design of the Integrated Care in Early Psychosis Study (ACCESS III).
    Lambert M; Schöttle D; Sengutta M; Ruppelt F; Rohenkohl A; Luedecke D; Nawara LA; Galling B; Falk AL; Wittmann L; Niehaus V; Sarikaya G; Handwerk U; Rothländer W; Rietschel L; Gagern C; Lange B; Meigel-Schleiff C; Naber D; Schulte-Markwort M; Krüger H; Unger HP; Sippel S; Ott S; Romer G; Daubmann A; Wegscheider K; Correll CU; Schimmelmann BG; Bock T; Gallinat J; Karow A
    Early Interv Psychiatry; 2018 Feb; 12(1):96-106. PubMed ID: 27618789
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Four-Year Follow-up of Cognitive Behavioral Therapy in Persons at Ultra-High Risk for Developing Psychosis: The Dutch Early Detection Intervention Evaluation (EDIE-NL) Trial.
    Ising HK; Kraan TC; Rietdijk J; Dragt S; Klaassen RM; Boonstra N; Nieman DH; Willebrands-Mendrik M; van den Berg DP; Linszen DH; Wunderink L; Veling W; Smit F; van der Gaag M
    Schizophr Bull; 2016 Sep; 42(5):1243-52. PubMed ID: 26994397
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Positive family environment predicts improvement in symptoms and social functioning among adolescents at imminent risk for onset of psychosis.
    O'Brien MP; Gordon JL; Bearden CE; Lopez SR; Kopelowicz A; Cannon TD
    Schizophr Res; 2006 Jan; 81(2-3):269-75. PubMed ID: 16309893
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.